Resolving Gene Editing Technology's Ethical and Regulatory Challenges

Posted 13 December 2017 By Vidya Narayanaswami, PhD, Dr. Stephen F. Amato

placeholder+image This article provides an overview of biomedical applications of gene editing technology, addresses ethical and regulatory challenges associated with its implementation for therapeutic development, and proposes approaches for overcoming these challenges.

Share this article:

Categories: Biologics and biotechnology, Ethics, Features, FDA

Tags: Gene Editing, Gene Therapy, CRISPR, Cas9

Regulatory Exchange: Latest Updates From the Community